Oxis Intl Inc (OXIS) 0.0165 $OXIS
OXIS International announces plans to Enter the Cannabis Biotech Sector, Completion of Financing, Changes to the Board of Directors
PR Newswire - Sun Aug 10, 11:33PM CDT
Oxis International, Inc. (OXI.PA) announced today company management has changed the business and plans to enter the cannabis biotech space. To support the change of business, the company completed a $1.425 million financing. Mr. Anthony Cataldo has joined the OXIS Board of Directors and will serve as Chairman of the Board.
Cardiovascular Disease - Pipeline Review: Latest updates and review of key players
M2 - Wed Jan 09, 5:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/9szlks/cardiovascular) has announced the addition of Global Markets Direct's new report "Cardiovascular Disease - Pipeline Review, H2 2012" to their offering. This report provides information on the therapeutic development for Cardiovascular Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiovascular Disease. Cardiovascular Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Scope - A snapshot of the global therapeutic scenario for Cardiovascular Disease. - A review of the Cardiovascular Disease products under development by
OXIS International announces plans to Enter the Cannabis Biotech Sector, Completion of Financing, Changes to the Board of Directors
PR Newswire - Sun Aug 10, 11:33PM CDT
Oxis International, Inc. (OXI.PA) announced today company management has changed the business and plans to enter the cannabis biotech space. To support the change of business, the company completed a $1.425 million financing. Mr. Anthony Cataldo has joined the OXIS Board of Directors and will serve as Chairman of the Board.
Cardiovascular Disease - Pipeline Review: Latest updates and review of key players
M2 - Wed Jan 09, 5:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/9szlks/cardiovascular) has announced the addition of Global Markets Direct's new report "Cardiovascular Disease - Pipeline Review, H2 2012" to their offering. This report provides information on the therapeutic development for Cardiovascular Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiovascular Disease. Cardiovascular Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Scope - A snapshot of the global therapeutic scenario for Cardiovascular Disease. - A review of the Cardiovascular Disease products under development by
